Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07915570

Salivary IL-8 and Serum IL-6 as Biomarkers for Oral Potentially Malignant Disorders in Smokers and Never-Smokers

Sponsor: British University In Egypt

View on ClinicalTrials.gov

Summary

The goal of this observational study is to learn whether two inflammatory proteins, interleukin-8 (IL-8) measured in saliva and interleukin-6 (IL-6) measured in blood serum, can help distinguish adults with oral potentially malignant disorders (OPMDs), such as oral lichen planus and leukoplakia, from adults with healthy oral mucosa, and whether smoking changes these protein levels. The main questions it aims to answer are: * Do salivary IL-8 and serum IL-6 levels differ between people with OPMDs and healthy controls, and does this difference depend on smoking status? * How well do IL-8 and IL-6, alone or combined, discriminate people with OPMDs from healthy controls? Researchers compared healthy never-smokers, healthy current smokers, never-smokers with OPMDs, and current smokers with OPMDs. An additional exploratory group of current smokers with oral squamous cell carcinoma (OSCC) was compared with current smokers with OPMDs. Participants provided an unstimulated whole saliva sample and a blood sample at a single visit, and completed a clinical, periodontal, and tobacco-use assessment. No treatment was assigned as part of the study.

Official title: Diagnostic Performance of Salivary Interleukin-8 and Serum Interleukin-6 for Oral Potentially Malignant Disorders: Effect Modification by Smoking Status - A Cross-Sectional Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

250

Start Date

2026-10-01

Completion Date

2027-01-30

Last Updated

2026-11-04

Healthy Volunteers

Yes

Interventions

DIAGNOSTIC_TEST

Salivary IL-8 and Serum IL-6 Measurement

No treatment is assigned. All participants provide a single unstimulated whole saliva sample, analyzed for interleukin-8 (IL-8), and a blood sample, from which serum is analyzed for interleukin-6 (IL-6). Concentrations are measured by immunoassay and expressed in pg/mL. Biomarker levels are compared between groups and evaluated, individually and combined, for diagnostic discrimination.

Locations (1)

The British University in Egypt

Cairo, Egypt